FDA approves Itovebi for locally advanced, metastatic breast cancer
The U.S. Food and Drug Administration has approved Itovebi (inavolisib), in combination with palbociclib (Ibrance) and ...
InnovationRx: This Startup’s Emotion-Sensing Glasses Could Be Used To Improve Mental Health
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here.
Targeted Oncology10h
KEYNOTE-522 Trial: Pembrolizumab Boosts Survival in Early TNBC
In the randomized, double-blind, phase 3 study, experts explored treatment with neoadjuvant pembrolizumab (Keytruda) plus chemotherapy, followed by adjuvant pembrolizumab, in patients aged 18 years ...
Targeted Oncology12h
FDA Clears NDA of Intravesical Mitomycin in Non–Muscle-Invasive Bladder Cancer
A Prescription Drug User Fee Act target action date of June 13, 2025, has been set for the new drug application of ...